Shennon Biotechnologies · 5 hours ago
Scientist / Senior Scientist - TCR engineering and TCE development
Shennon Biotechnologies is a well-funded biotech startup focused on advancing immunotherapies for cancer and autoimmune diseases. They are seeking a Senior Scientist with expertise in TCR affinity maturation and T cell engager development to lead engineering efforts and collaborate with an interdisciplinary team.
BiotechnologyLife ScienceMedical
Responsibilities
Design libraries and perform TCR affinity maturation using yeast display
Lead TCR engineering efforts for enhanced affinity, specificity, and stability
Partner with AI/ML scientists to design sequences and libraries, contributing to iterative design-build-test cycles to advance therapeutic candidates
Collaborate with the team to develop TCEs and conduct in vitro functional assays to assess efficacy and safety
Work with CRO on TCR/TCE production and binding characterization
Qualification
Required
PhD in Biochemistry, Molecular Biology, Bioengineering, Immunology, or a related field
Expertise in yeast display technologies, and high-throughput TCR/antibody screening
Experience in TCR, antibody or protein engineering, including affinity maturation, deep mutational scanning, cross-reactivity, and biophysical property optimization
Experience with TCR/antibody library construction, screening, and binding measurement
Fundamental understanding of TCR/antibody and structure-function relationships
Familiarity with protein structure analysis tools (Pymol, Chimera, MOE)
Ability to work in a fast-paced startup environment, take initiative, and drive projects forward independently
Excellent communication and collaboration skills
Preferred
Experience with bispecific antibodies and format screening
Background in T Cell Engager development
Experience with mammalian expression systems and protein purification techniques
Benefits
4% Salary 401K match
Daily lunches
Commuter Benefits
Unlimited snacks and drinks
Medical, Dental, Vision; 100% Premium Covered
Disability Insurance
Life Insurance
Workplace Insurance
Company
Shennon Biotechnologies
ShennonBio analyzes and manipulates a massive number of cells on the single cell level to develop better treatments for human diseases.
Funding
Current Stage
Early StageTotal Funding
$13MKey Investors
DCVC
2023-03-13Seed· $13M
Recent News
2025-02-10
2023-03-21
Company data provided by crunchbase